<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>242822</rcn>
  <id>101099232</id>
  <acronym>MACOV</acronym>
  <teaser>Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer. About 300,000 women are diagnosed with ovarian cancer each year and the number of deaths is estimated at 180,000 worldwide each year. Ovarian cancer metastasizes early in its...</teaser>
  <objective><![CDATA[Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer. About 300,000 women are diagnosed with ovarian cancer each year and the number of deaths is estimated at 180,000 worldwide each year. Ovarian cancer metastasizes early in its development, often before it's diagnosed. Ovarian cancer treatment involves surgery with frontline platinum-based chemotherapy. As many as 15-30% of patients with ovarian cancer have primary platinum-resistant or refractory disease. The recurrence of ovarian cancer is now considered a sign of an incurable disease (it becomes platinum-resistant).
The project MACOV aims to develop an innovative allogeneic, “ready-to-use” macrophage-based therapy for platinum-resistant ovarian cancer. This is a ground-breaking, first in class therapy that shows very high efficacy in multiple solid tumors of unmet medical need. 
These cells are equipped with targeted therapy drugs complexed with the carrier protein ensuring their stability in the carrier cell. The protein-drug complex is transferred specifically to cancer cells. The whole concept of this cell therapy is based on the groundbreaking scientific discoveries of MDC (Macrophage-Drug Conjugate). Two European Research Council (ERC) grants were received to study the molecular basis of the discovered mechanism - in 2016 and 2020. In 2018 this project was selected to be promoted as one of the 10 European projects during ERC 10th Anniversary. 
The MACOV project will generate of complete efficacy data package for the pre-clinical development of MDC-735 product, consisting of efficacy in multiple  animal models for platinum-resistant ovarian cancer, PK, PD and toxicology study as well as consolidate IP and validate business case. The result of the project will be a validated cell therapy product for platinum-refractory ovarian cancer, tested for effectiveness and ready-to-use for the Phase I clinical trial.]]></objective>
  <title>Macrophage-based immunotherapy of platinum-resistant ovarian cancer</title>
  <keywords>cell therapy, macrophage, immunotherapy, ovarian cancer</keywords>
  <totalCost>2499998.75</totalCost>
  <ecMaxContribution>2499998.75</ecMaxContribution>
  <startDate>2022-11-01</startDate>
  <endDate>2026-04-30</endDate>
  <ecSignatureDate>2022-10-27</ecSignatureDate>
  <duration>42</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101099232</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-10-20 17:38:03</sourceUpdateDate>
  <contentCreationDate readOnly="true">2022-11-09 17:21:40</contentCreationDate>
  <contentUpdateDate>2025-11-19 10:16:45</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-19 10:16:53</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>439083</rcn>
        <id>439083-first-in-class-cell-therapy-for-solid-tumours</id>
        <title>First-in-class cell therapy for solid tumours</title>
        <contentUpdateDate>2023-03-27 15:36:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55631</rcn>
        <title>HORIZON-EIC-2022-TRANSITION-01</title>
        <identifier>HORIZON-EIC-2022-TRANSITION-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55631</rcn>
        <title>HORIZON-EIC-2022-TRANSITION-01</title>
        <identifier>HORIZON-EIC-2022-TRANSITION-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2499998.75" terminated="false" sme="true" netEcContribution="2499998.75" totalCost="2499998.75" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1978961</rcn>
        <id>917195141</id>
        <vatNumber>PL5252640606</vatNumber>
        <legalName>CELLIS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA</legalName>
        <shortName>CELLIS</shortName>
        <address>
          <street>GENERALA ZAJACZKA 26</street>
          <city>WARSAW</city>
          <postalCode>01-510</postalCode>
          <country>PL</country>
          <geolocation>50.4278689,21.283795925659824</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Miasto Warszawa</name>
              <rcn>1465389</rcn>
              <nutsCode>PL911</nutsCode>
              <parents>
                <region>
                  <name>Warszawski stołeczny</name>
                  <rcn>1465070</rcn>
                  <nutsCode>PL91</nutsCode>
                  <parents>
                    <region>
                      <name>Makroregion województwo mazowieckie</name>
                      <rcn>1465069</rcn>
                      <nutsCode>PL9</nutsCode>
                      <parents>
                        <region>
                          <name>Poland</name>
                          <rcn>425101864</rcn>
                          <nutsCode>PL</nutsCode>
                          <euCode>PL</euCode>
                          <isoCode>PL</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Poland</name>
              <rcn>425101864</rcn>
              <nutsCode>PL</nutsCode>
              <euCode>PL</euCode>
              <isoCode>PL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706907</rcn>
        <id>HORIZON_HORIZON-EIC-2022-TRANSITIONOPEN-01</id>
        <code>HORIZON-EIC-2022-TRANSITIONOPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Transition Open 2022</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1361031</rcn>
        <id>101099232_209821_PUBLIHORIZON</id>
        <title>Abstract 6174: Macrophage-based immunotherapy of platinum-resistant ovarian cancer</title>
        <details>
          <authors>Jan Brancewicz, Maciej Bialasek, Bartłomiej Taciak, Ilona Marszalek, Konrad Gabrusiewicz, Tomasz Rygiel, Magdalena Krol</authors>
          <journalNumber>85</journalNumber>
          <journalTitle>Cancer Research</journalTitle>
          <publishedPages/>
          <publishedYear>2025</publishedYear>
          <publisher>American Association for Cancer Research (AACR)</publisher>
        </details>
        <identifiers>
          <doi>10.1158/1538-7445.AM2025-6174</doi>
          <issn>0008-5472</issn>
        </identifiers>
        <sourceUpdateDate>2025-08-14 02:04:01</sourceUpdateDate>
        <contentUpdateDate>2025-09-16 11:28:50</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/CONFERENCE_PROCEEDING</code>
              <title>Conference proceedings</title>
              <displayCode readOnly="true">/Conference proceedings</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1380129</rcn>
        <id>101099232_246104_PUBLIHORIZON</id>
        <title>Isolated targeted delivery system for the treatment of ovarian cancer</title>
        <details>
          <authors>Magdalena Król, Tomasz Rygiel, Jan Brancewicz, Paulina Ochońska, Michał Ostrowski, Robert Zagożdżon</authors>
          <journalNumber/>
          <journalTitle>World Intellectual Property Organization</journalTitle>
          <publishedPages/>
          <publishedYear>2024</publishedYear>
          <publisher>WIPO PATENTSCOPE</publisher>
        </details>
        <sourceUpdateDate>2025-10-28 03:20:27</sourceUpdateDate>
        <contentUpdateDate>2025-10-30 11:34:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode readOnly="true">/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1361019</rcn>
        <id>101099232_209822_PUBLIHORIZON</id>
        <title>Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope</title>
        <details>
          <authors>Jan Brancewicz, Irena Barbara Padzińska-Pruszyńska, Małgorzata Kubiak, Paulina Kucharzewska</authors>
          <journalNumber>14</journalNumber>
          <journalTitle>Cells</journalTitle>
          <publishedPages/>
          <publishedYear>2025</publishedYear>
          <publisher>MDPI AG</publisher>
        </details>
        <identifiers>
          <doi>10.3390/CELLS14130995</doi>
          <issn>2073-4409</issn>
        </identifiers>
        <sourceUpdateDate>2025-08-14 02:04:01</sourceUpdateDate>
        <contentUpdateDate>2025-09-16 11:28:44</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode readOnly="true">/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1380120</rcn>
        <id>101099232_246103_PUBLIHORIZON</id>
        <title>Macrophage-drug conjugate as a cell-based therapy for platinum-resistant ovarian cancer</title>
        <details>
          <authors>Brancewicz, Jan; Lipinski, Waldemar; Taciak, Bartlomiej; Kurpiel, Daria; Osadchuk, Olha; Gabrusiewicz, Konrad; et al.</authors>
          <journalNumber/>
          <journalTitle>ESGCT Congress 2023</journalTitle>
          <publishedPages/>
          <publishedYear>2023</publishedYear>
          <publisher>The poster was published online after the conference on Figshare.</publisher>
        </details>
        <identifiers>
          <doi>10.6084/M9.FIGSHARE.29647874.V1</doi>
        </identifiers>
        <sourceUpdateDate>2025-10-28 03:20:27</sourceUpdateDate>
        <contentUpdateDate>2025-10-30 11:33:57</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode readOnly="true">/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/OTHER</code>
              <title>Other</title>
              <displayCode readOnly="true">/Other</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1068407</rcn>
        <id>101099232_14_DELIVHORIZON</id>
        <title>Website and project logo</title>
        <description>Project logo and website information about the MDC-735 for ovarian cancer treatment and publication of data</description>
        <sourceUpdateDate>2024-03-23 08:35:39</sourceUpdateDate>
        <contentUpdateDate>2024-03-28 14:30:05</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode readOnly="true">/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/DEC</code>
              <title>Websites, patent fillings, videos etc.</title>
              <displayCode readOnly="true">/Websites, patent fillings, videos etc.</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webLink source="corda" represents="project" type="projectDeliverable">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <defaultLanguage>en</defaultLanguage>
              <id>96f097caee671e8dfc7f1649242ecce1</id>
              <physUrl><![CDATA[https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f5c82eaf&appId=PPGMS]]></physUrl>
            </webLink>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1075945</rcn>
        <id>101099232_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - MACOV (Macrophage-based immunotherapy of platinum-resistant ovarian cancer)</title>
        <teaser>Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer. About 300,000 women are diagnosedwith ovarian cancer each year and the number of deaths is estimated at 180,000 worldwide each year. Ovarian cancer metastasizesearly in its development...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-04-07 13:11:41</sourceUpdateDate>
        <contentUpdateDate>2024-04-09 12:15:22</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/223</code>
        <title>surgery</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/surgery</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/643</code>
        <title>immunotherapy</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/immunology/immunotherapy</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC</code>
        <title>HORIZON EIC Grants</title>
        <description>HORIZON EIC Grants</description>
        <displayCode readOnly="true">/HORIZON EIC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
